相关实验视频

Updated: Jul 13, 2025

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

中度至重度脱发区的治疗方法:系统叙事审查

Alexander Egeberg^1,2, Louise Linsell³, Erin Johansson⁴

¹Department of Dermatology, Bispebjerg University Hospital, Copenhagen University, Copenhagen, Denmark. alexander.egeberg@gmail.com.

Dermatology and therapy

|October 13, 2023

概括

巴里西提尼布是一种简氏激酶 (JAK) 抑制剂,显示出强有力的证据,用于治疗严重的脱发性白发症 (AA). 目前的AA治疗方法往往缺乏强有力的临床试验数据,这凸显了需要更好地评估治疗的需要.

科学领域:

皮肤病学皮肤病学
药理学药理学是指药理学的学科.
临床试验临床试验

背景情况:

脱发区 (AA) 的管理缺乏普遍共识,治疗方法经常被非标签使用.
需要了解在临床实践中支持AA治疗的证据.

研究的目的:

系统地审查和叙述地分析成年人中适度至重度AA治疗疗法的疗效和耐受性的证据.
确定当前AA管理策略的最强有力的证据.

主要方法:

对2557个已识别的记录进行系统的文献审查,保留53个用于数据提取.
包括随机对照试验 (RCT),非随机试验和观察性研究.
专注于适度至重度脱发区患者的成年患者的治疗.

主要成果:

跨药物类别的异质数据报告与不一致的终点.
雅克抑制剂,特别是巴里西提尼布,在五个RCT中表现出与安慰剂相比的一致的好处.
其他药物类别对中度至重度的AA显示出有限的疗效和低的头发再生率.

结论:

目前的中度至重度AA管理通常使用缺乏强有力的临床评估的治疗方法.
巴里西提尼布和其他口服JAK抑制剂对严重的AA具有最强的证据基础.
复发很常见,不良反应与已知的安全概况一致.

关键词:

阿洛佩西亚 areata 地区.巴里西提尼布 (Baricitinib) 是一种药物.雅努斯酶抑制剂的使用系统性审查系统性审查治疗方法治疗方法

更多相关视频

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...